These findings provide supportive evidenceconsistent with prior studies that activation of MEK5 upregulates breast cancer cellproliferation, migration and promotes the mesenchymal phenotype through FRA-1 signalingactivation. This evidence concerns the gene MAP2K5 and breast carcinoma.